Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: A position paper from the Italian Registry

Published on Sep 1, 2010in Digestive and Liver Disease3.57
· DOI :10.1016/J.DLD.2010.04.016
Marco Del Chiaro31
Estimated H-index: 31
Alessandro Zerbi57
Estimated H-index: 57
+ 6 AuthorsMassimo Falconi105
Estimated H-index: 105
(University of Verona)
Abstract In Italy, pancreatic cancer is the fifth leading cause of tumor related death with about 7000 new cases per year and a mortality rate of 95%. In a recent prospective epidemiological study on the Italian population, a family history was found in about 10% of patients suffering from a ductal adenocarcinoma of the pancreas (PDAC). A position paper from the Italian Registry for Familial Pancreatic Cancer was made to manage these high-risk individuals. Even though in the majority of high-risk individuals a genetic test to identify familial predisposition is not available, a screening protocol seems to be reasonable for subjects who have a >10-fold greater risk for the development of PDAC. However this kind of screening should be included in clinical trials, performed in centers with high expertise in pancreatic disease, using the least aggressive diagnostic modalities.
📖 Papers frequently viewed together
288 Citations
233 Citations
298 Citations
#1Stefano Partelli (University of Verona)H-Index: 43
#2Carlos Fernandez-del Castillo (Harvard University)H-Index: 101
Last. Roberto Salvia (University of Verona)H-Index: 52
view all 11 authors...
Intraductal papillary mucinous neoplasms (IPMNs) were defined by the World Health Organization (WHO) in 2000 as intraductal mucin-producing neoplasms that can involve the main pancreatic duct but may also affect the side branches or a combination of the two.1 Currently, IPMNs are the most common of the cystic neoplasms of the pancreas2 and an increasingly well-recognized clinical and pathologic entity accounting for 8% to 20% of all resected pancreatic neoplasms.3 According to the International ...
83 CitationsSource
#1Randall E. Brand (University of Pittsburgh)H-Index: 71
#2Julia B. Greer (University of Pittsburgh)H-Index: 25
Last. Michelle A. Anderson (UM: University of Michigan)H-Index: 54
view all 11 authors...
Background & Aims Cigarette smoking is an established risk factor for pancreatic cancer, but there is conflicting evidence regarding the effects of alcohol consumption. The effects of cigarettes and alcohol on age of sporadic pancreatic cancer diagnosis have not been examined; we evaluated the independent and synergistic effects of lifetime cigarette smoking and alcohol consumption on age at pancreatic cancer diagnosis in the United States. Methods We analyzed data on cigarette smoking and alcoh...
52 CitationsSource
#1Donghui Li (University of Texas MD Anderson Cancer Center)H-Index: 23
#2Sai Ching J. Yeung (University of Texas MD Anderson Cancer Center)H-Index: 34
Last. James L. Abbruzzese (University of Texas MD Anderson Cancer Center)H-Index: 134
view all 5 authors...
Background & Aims Antidiabetic drugs have been found to have various effects on cancer in experimental systems and in epidemiologic studies, although the association between these therapeutics and the risk of human pancreatic cancer has not been explored. We investigated the effect of antidiabetic therapies on the risk of pancreatic cancer. Methods A hospital-based case-control study was conducted at M. D. Anderson Cancer Center from 2004 to 2008 involving 973 patients with pancreatic adenocarci...
666 CitationsSource
#1William M. Steinberg (WashU: Washington University in St. Louis)H-Index: 27
#2Jamie S. Barkin (Mayo Clinic)H-Index: 1
Last. Michael J. Levy (Mayo Clinic)H-Index: 107
view all 7 authors...
24 CitationsSource
#1Donghui LiH-Index: 23
#2Jeffrey S. Morris (University of Texas MD Anderson Cancer Center)H-Index: 76
Last. James L. Abbruzzese (University of Texas MD Anderson Cancer Center)H-Index: 134
view all 7 authors...
Context Obesity has been implicated as a risk factor for pancreatic cancer. Objective To demonstrate the association of excess body weight across an age cohort and the risk, age of onset, and overall survival of patients with pancreatic cancer. Design, Setting, and Participants A case-control study of 841 patients with pancreatic adenocarcinoma and 754 healthy individuals frequency matched by age, race, and sex. The study was conducted at a university cancer center in the United States from 2004...
418 CitationsSource
Alcohol use has been implicated in the etiology of cancers of the mouth, pharynx and larynx, esophagus, breast, liver, and colorectum (1). The epidemiologic evidence for the role of alcohol use in the etiology of pancreatic cancer is equivocal. At least 60 analytical epidemiologic studies (2–4), including 13 prospective cohort studies (5–17), have examined the association between alcohol use and incidence and/or mortality of pancreatic cancer. Many studies did not find any association (3). Eight...
89 CitationsSource
#1Li Jiao (NIH: National Institutes of Health)H-Index: 35
#2Panagiota N. MitrouH-Index: 19
view all 7 authors...
Background:Smoking, alcohol use, diet, body mass index (calculated as weight in kilograms divided by height inmeterssquared),andphysicalactivityhavebeenstudied independently in relation to pancreatic cancer. We generatedahealthylifestylescoretoinvestigatetheirjoint effect on risk of pancreatic cancer. Methods: In the prospective National Institutes of Health–AARP Diet and Health Study, a total of 450416 participants aged 50 to 71 years completed the baseline food frequency questionnaire (1995-19...
161 CitationsSource
#1Jeanine M. Genkinger (Georgetown University)H-Index: 29
#2Donna Spiegelman (Harvard University)H-Index: 173
Last. Stephanie A. Smith-Warner (Harvard University)H-Index: 60
view all 28 authors...
Background: Few risk factors have been implicated in pancreatic cancer etiology. Alcohol has been theorized to promote carcinogenesis. However, epidemiologic studies have reported inconsistent results relating alcohol intake to pancreatic cancer risk. Methods: We conducted a pooled analysis of the primary data from 14 prospective cohort studies. The study sample consisted of 862,664 individuals among whom 2,187 incident pancreatic cancer cases were identified. Study-specific relative risks and 9...
173 CitationsSource
#1Rahul Pannala (Mayo Clinic)H-Index: 21
#2Ananda Basu (Mayo Clinic)H-Index: 56
Last. Suresh T. Chari (Mayo Clinic)H-Index: 103
view all 4 authors...
Summary Pancreatic cancer has a dismal prognosis because cancer-specific symptoms occur only at an advanced stage. If the cancer is to be discovered early, screening will need to be done in asymptomatic individuals. Because the incidence of pancreatic cancer is low, screening for asymptomatic cancer in the general population is not feasible; therefore, screening will need to be restricted to people at high risk of this disease. The proportion of patients with pancreatic cancer who also have hype...
457 CitationsSource
Statins Are Not Associated With a Reduced Risk of Pancreatic Cancer at the Population Level, When Taken at Low Doses for Managing Hypercholesterolemia: Evidence From a Meta-Analysis of 12 Studies
75 CitationsSource
Cited By52
#1Marco GalloH-Index: 16
Last. Francesco Giorgino (University of Bari)H-Index: 61
view all 19 authors...
Pancreatic cancer (PC) is a common cause of cancer-related death, due to difficulties in detecting early-stage disease, to its aggressive behaviour, and to poor response to systemic therapy. Therefore, developing strategies for early diagnosis of resectable PC is critical for improving survival. Diabetes mellitus is another major public health problem worldwide. Furthermore, diabetes can represent both a risk factor and a consequence of PC: nowadays, the relationship between these two diseases i...
#1Anja Wagner (EUR: Erasmus University Rotterdam)H-Index: 52
#2Stefan Aretz (University of Bonn)H-Index: 44
Last. Gabriela Möslein (HHU: University of Düsseldorf)H-Index: 38
view all 15 authors...
The scientific data to guide the management of Peutz-Jeghers syndrome (PJS) are sparse. The available evidence has been reviewed and discussed by diverse medical specialists in the field of PJS to update the previous guideline from 2010 and formulate a revised practical guideline for colleagues managing PJS patients. Methods: Literature searches were performed using MEDLINE, Embase, and Cochrane. Evidence levels and recommendation strengths were assessed using the Grading of Recommendations Asse...
#1Gabriele Capurso (UniSR: Vita-Salute San Raffaele University)H-Index: 56
#2Salvatore Paiella (University of Verona)H-Index: 23
Last. Massimo FalconiH-Index: 105
view all 8 authors...
Abstract Pancreatic cancer is one of the main causes of cancer-related death worldwide, with a survival rate around 9%. In Italy 13,500 new cases of pancreatic cancer occurred in 2019. It is estimated that at least 5% have a hereditary background. Surveillance is advisable for healthy individuals with specific genetic syndromes with or without family history of pancreatic cancer or members of families with multiple cases of pancreatic cancer, irrespective of genetic syndromes. In 2010 the Italia...
#2Yoshimi KiyozumiH-Index: 4
Last. Hiroyuki OnoH-Index: 14
view all 6 authors...
A family history of pancreatic cancer (PC) is a risk factor of PC, and risk levels increase as affected families grow in number and/or develop PC at younger ages. Familial pancreatic cancer (FPC) is defined as a client having at least two PC cases in a first degree relatives. In the narrow sense, FPC does not include some inherited cancer syndromes that are known to increase the risks of PC, such as Peutz–Jeghers syndrome (PJS), hereditary pancreatitis (HP), hereditary breast ovarian cancer synd...
3 CitationsSource
#2Kyoichi Takaori (Kyoto University)H-Index: 28
Last. Yoshimi KiyozumiH-Index: 4
view all 4 authors...
Family history of pancreatic cancer (PC) is a risk factor for PC development, and the risk level correlates with the number of affected families. A case of PC with : 1 PC cases in the first-degree relative is broadly defined as familial pancreatic cancer (FPC) and accounts for 5% to 10% of total PC cases. FPC possesses several epidemiological, genetic and clinicopathological aspects that are distinct from those of conventional PCs. In Western countries, FPC registries have been established since...
6 CitationsSource
#1Salvatore Paiella (University of Verona)H-Index: 23
#2Gabriele CapursoH-Index: 56
Last. Alessandro ZerbiH-Index: 57
view all 19 authors...
Surveillance programs on high-risk individuals (HRIs) can detect pre-malignant lesions or early pancreatic cancer (PC). We report the results of the first screening round of the Italian multicenter program supported by the Italian Association for the study of the Pancreas (AISP). The multicenter surveillance program included asymptomatic HRIs with familial (FPC) or genetic frailty (GS: BRCA1/2, p16/CDKN2A, STK11/LKB1or PRSS1, mutated genes) predisposition to PC. The surveillance program included...
16 CitationsSource
#1Jennifer L. Geurts (MCW: Medical College of Wisconsin)H-Index: 8
Pancreatic cancer (PC) is a genetically heterogenous disease with approximately 10% of cases attributed to a germline gene mutation. Family history of PC increases the risk of developing the disease two- to threefold when a single first-degree relative is affected. However, current genetic testing strategies identify a germline mutation in less than a third of suspected hereditary cases, while the remaining two-thirds or more without a causative mutation are considered to have a familial form of...
#1Marianna SignorettiH-Index: 13
#2Marco J. Bruno (EUR: Erasmus University Rotterdam)H-Index: 23
Last. Gabriele CapursoH-Index: 56
view all 6 authors...
BackgroundData on surveillance for pancreatic ductal adenocarcinoma (PDAC) in high-risk individuals (HRIs) with “familial pancreatic cancer” (FPC) and specific syndromes are limited and heterogeneo...
18 CitationsSource
#1Ajay V. Maker (UIC: University of Illinois at Chicago)H-Index: 24
#2Raashid Sheikh (UIUC: University of Illinois at Urbana–Champaign)H-Index: 1
Last. Diabetes ControlH-Index: 1
view all 4 authors...
Purpose Indications for total pancreatectomy (TP) have increased, including for diffuse main duct intrapapillary mucinous neoplasms of the pancreas and malignancy; therefore, the need persists for surgeons to develop appropriate endocrine post-operative management strategies. The brittle diabetes after TP differs from type 1/2 diabetes in that patients have absolute deficiency of insulin and functional glucagon. This makes glucose management challenging, complicates recovery, and predisposes to ...
8 CitationsSource
#2Kyoichi TakaoriH-Index: 28
Last. Toru Shimosegawa (Tohoku University)H-Index: 26
view all 30 authors...
: Familial pancreatic cancer (FPC) is broadly defined as two first-degree-relatives with pancreatic cancer (PC) and accounts for 4%-10% of PC. Several genetic syndromes, including Peutz-Jeghers syndrome, hereditary pancreatitis, hereditary breast-ovarian cancer syndrome (HBOC), Lynch syndrome, and familial adenomatous polyposis (FAP), also have increased risks of PC, but the narrowest definition of FPC excludes these known syndromes. When compared with other familial tumors, proven genetic alter...
40 CitationsSource